"Conclusions There were significantly lower viral loads and viable cultures in the ivermectin group, which could lead to shortening isolation time in these patients."
n= 89 (47 + 42) in pa 72 % vs 50 %
Če povzamemo to študijo, na manjši skupini ljudi so preizkusili ivermectin, rezultati kažejo da bi
lahko uporaba ivermectina
skrajšala potreben čas karantene (izolacije) pri pozitivnih osebah s COVID-om.
Ne vem
AndY1, po mojem razumevanju nekako ta študija ne potrjuje čudežno delovanje iveremctina.
Kaj to pomeni "čudežno delovanje" neke snovi, lahko vidiš na primeru sifilisa. Pred pojavom bakterijske rezistence, ko se je začelo uporabljat penicilne, je oboleli za sifilisom prejel 100 mg penicilina G enkrat in je bil
pozdravljen.
Kar se tiče študije, maja 2020 bi bil navdušen nad njo, danes, maja 2021 bi pa pričakoval večjo skupino pacientov, bolje definirane endpointe in bolj relevantne razlike med tretirano in placebo skupino. Bolj kot se to odmika, bolj je videti, da so problem vsebinska vprašanja (učinkovitost) ne pa organizacijska vprašanja.
Pod samim medrivx člankom imaš sledeč komentar, ki opiše težave članka:
This research is problematic.
First, this clinical trial's primary outcome measures were as attached below. And authors did not mention 2 out of 3 primary outcome measures. These are not good omissions apparently.
Second even the primary outcome measure they used was not specified before the study. Authors used ct cut value of 30, which was arbitrary. Authors explain why they did not use 40, but they must have used 40 if that leads to the good results. And that is not a clinical trial.
They did not correct for multiple comparisons across three primary endpoints, either, which they should have done as there are three primary endpoints.
Second as the figure 2 and the table shows the ct values of two groups before the intervention are close to statistically significant differences (p = 0.10).
And as the figure 2 shows this group difference did not show even a hint of change at day 6! The two groups were almost statistically different from the beginning and that did not change visually at day 6 apparently. I can't see any hints of effects of IVM from this study.
Lay persons are watching this study, and they say they love IVM and hate vaccine and let's use IVM instead of vaccine based on this study's result. We hope authors do the proper research. They should provide three primary endpoints, correct the preexisting differences, and correct multiple comparisons, and should provide apparent conclusions.